116 related articles for article (PubMed ID: 12834817)
41. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.
Shyu HY; Fong CS; Fu YP; Shieh JC; Yin JH; Chang CY; Wang HW; Cheng CW
Clin Chim Acta; 2010 Jun; 411(11-12):840-5. PubMed ID: 20193673
[TBL] [Abstract][Full Text] [Related]
42. NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines.
Bruge F; Virgili S; Cacciamani T; Principi F; Tiano L; Littarru GP
Biofactors; 2008; 32(1-4):71-81. PubMed ID: 19096102
[TBL] [Abstract][Full Text] [Related]
43. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
Chung JE; Chang BC; Lee KE; Kim JH; Gwak HS
Eur J Clin Pharmacol; 2015 Oct; 71(10):1229-36. PubMed ID: 26257249
[TBL] [Abstract][Full Text] [Related]
44. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
45. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
46. High frequency of NAD(P)H:quinone oxidoreductase 1 (NQO1) C(609)T germline polymorphism in MDS/AML with trisomy 8.
Zachaki S; Stavropoulou C; Koromila T; Manola KN; Kalomoiraki M; Daraki A; Koumbi D; Athanasiadou A; Kanavakis E; Kollia P; Sambani C
Leuk Res; 2013 Jul; 37(7):742-6. PubMed ID: 23643325
[TBL] [Abstract][Full Text] [Related]
47. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
48. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma.
Chiu MM; Ko YJ; Tsou AP; Chau GY; Chau YP
Histol Histopathol; 2009 Oct; 24(10):1223-32. PubMed ID: 19688691
[TBL] [Abstract][Full Text] [Related]
49. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
50. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
51. Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues.
Tseng LM; Yin PH; Tsai YF; Chi CW; Wu CW; Lee LM; Lee HC
Oncol Rep; 2009 May; 21(5):1169-74. PubMed ID: 19360290
[TBL] [Abstract][Full Text] [Related]
52. 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Steiner M; Hillenbrand M; Borkowsi M; Seiter H; Schuff-Werner P
Cancer Lett; 1999 Jan; 135(1):67-71. PubMed ID: 10077223
[TBL] [Abstract][Full Text] [Related]
53. Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.
Nishida-Tamehiro K; Kimura A; Tsubata T; Takahashi S; Suzuki H
PLoS One; 2022; 17(7):e0272090. PubMed ID: 35905076
[TBL] [Abstract][Full Text] [Related]
54. Iron deficiency aggravates DMNQ-induced cytotoxicity via redox cycling in kidney-derived cells.
Yoshihara D; Fujiwara N; Eguchi H; Sakiyama H; Suzuki K
Free Radic Res; 2022; 56(7-8):544-554. PubMed ID: 36469660
[TBL] [Abstract][Full Text] [Related]
55. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
[TBL] [Abstract][Full Text] [Related]
56. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
57. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells.
Siegel D; Ryder J; Ross D
Toxicol Lett; 2001 Dec; 125(1-3):93-8. PubMed ID: 11701227
[TBL] [Abstract][Full Text] [Related]
58. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
Ma QL; Yang JF; Shao M; Dong XM; Chen B
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
[TBL] [Abstract][Full Text] [Related]
59. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
[TBL] [Abstract][Full Text] [Related]
60. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS.
Fern L; Pallis M; Ian Carter G; Seedhouse C; Russell N; Byrne J
Br J Haematol; 2004 Jul; 126(1):63-71. PubMed ID: 15198733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
